Search Results 1191-1200 of 18491 for prednisone

1. Cervical spondylosis - Doctors and departments - Mayo Clinic

   As people age, the spinal disks in the neck shrink and bone spurs often develop. If symptoms occur, nonsurgical treatments are usually effective.

2. Publications - Matt R. Starr, M.D. - Mayo Clinic

   Starr MR, Maguire LJ, Salomão DR. Bilateral Corneal Deposits 1 Week After Starting Oral Prednisone Therapy. JAMA Ophthalmol. 2018 May 01; 136(5):591-592. View ...

3. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... prednisone within the 7 days prior to apheresis; Received either of the following: An allogenic stem cell transplant within 6 months before apheresis ...

4. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

   Systemic corticosteroids at physiologic doses not to exceed 10 mg/day of prednisone or its equivalent; Steroids as pre-medication for hypersensitivity ...

5. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   Subjects with active autoimmune disease or on steroid therapy of >10 mg/day prednisone or equivalent. Subjects who have undergone bone marrow or solid organ ...

6. Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

   Systemic treatment with corticosteroids (>10 mg daily prednisone equivalents). Note: Short-course systemic corticosteroids (eg, prevention/treatment for ...

7. Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients with Chronic Rhinosinusitis and Nasal Polyps - Mayo Clinic

   However, patients on chronic steroids equal to ≤ 20 mg of prednisone daily, are eligible. Patients who were on a different biologic medication in the ...

8. A Study to Evaluate Posoleucel ALVR105 to Treat Kidney Transplant Recipients with BK Viremia - Mayo Clinic

   Ongoing therapy with high-dose systemic corticosteroids (i.e, prednisone dose > 0.5 mg/kg/day or equivalent). Patients who received, or are planned to ...

9. Clinical Trials - AUTO1 in Relapsed or Refractory B-ALL

   Participation eligibility · Steroids: Therapeutic doses of corticosteroids (greater than 10 mg daily of prednisone or its equivalent) within 7 days of ...

10. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

    ... prednisone or equivalent within 2 weeks prior to first dose of cevostamab and, if applicable, tocilizumab premedication prior to first dose of cevostamab.